COMMUNIQUÉS West-GlobeNewswire

AveXis to Initiate Screening for Remaining Patients in Pivotal Trial of AVXS-101 for SMA Type 1 Following Review of Preliminary Data from First Three Patients
30/01/2018
CHICAGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, [...]
resTORbio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
30/01/2018
BOSTON, Jan. 30, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging- [...]
Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility
30/01/2018
SANTA BARBARA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today provided an update on its pre-market approval (PMA) supplement for [...]
FOR IMMEDIATE RELEASE: The importance of mental health literacy among all of the awareness
30/01/2018
HALIFAX, Nova Scotia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Today our media feeds will be filled with support for mental illness and it will feel like awareness is high, but awareness alone is not enough. “While mental [...]
Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition
30/01/2018
Washington, DC, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In its response to the U.S. Department of Health and Human Services’ latest Request for Information on Promoting Health Care Choice and Competition Across the United [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2017
30/01/2018
Communiqué de presse Villepinte, le 30 janvier 2018 DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l' [...]
Invitation to Idorsia's full year results 2017 webcast and conference call
30/01/2018
Idorsia will publish its full year financial results 2017 on Tuesday 6 February 2018 at 07:00 CET. An investor conference call and webcast will be held to discuss the results on the same day at 14:00 CET / 13:00 GMT / [...]
CORRECTING and REPLACING -- Innovate Biopharmaceuticals Announces Successful Merger Completion
30/01/2018
RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT ) please note that the stock symbol for Monster Digital, Inc [...]
Vaccinex, Inc. to Host Key Opinion Leader Luncheon on Huntington’s Disease
30/01/2018
ROCHESTER, N.Y., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies and other [...]
Local Volunteers Join America’s Toothfairy Smile Drive to Collect Oral Care Products for Royal Oak’s Teen Clean Closet
30/01/2018
ROYAL OAK, Mich., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Designed to raise awareness of the importance of oral health and collect oral care products for underserved children, the America’s ToothFairy Smile Drive is being [...]
Typenex® Medical Launches new line of Holmium Laser Fibers
30/01/2018
CHICAGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Typenex Medical , an industry leader in medical devices and supplies, today, announced it has launched Fibernex TM , a line of single-use and reusable holmium laser fibers [...]
Achaogen Announces Upgraded Status for Plazomicin Fill Manufacturer
30/01/2018
-- McPherson, Kansas facility compliance status amended to Voluntary Action Indicated (VAI) -- -- VAI status provides a clear regulatory path for potential approval of plazomicin out of McPherson facility -- SOUTH SAN [...]
Release date of annual report 2017 and audio cast
30/01/2018
Copenhagen, 2018-01-30 15:54 CET (GLOBE NEWSWIRE) -- On Tuesday, 6 February 2018, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its annual report for 2017. ALK will host a meeting for analysts and institutional [...]
Theratechnologies to Announce Financial Results for Fiscal Year 2017
30/01/2018
MONTREAL, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH ) ( Theratechnologies ) announced today that it will issue its financial results for the fiscal year ended November 30, 2017, on Wednesday, [...]
Theratechnologies annoncera ses résultats pour l’exercice financier 2017
30/01/2018
MONTRÉAL, 30 janv. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH ) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers mercredi le 7 février 2018 pour l’exercice [...]
ARM and NAMCP Publish Study of Managed Care Medical Director Perspectives on Value Demonstration and Reimbursement for Regenerative and Advanced Therapies
30/01/2018
WASHINGTON, DC., Jan. 30, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute announced today the joint [...]
Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology
30/01/2018
HASBROUCK HEIGHTS, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) reports today that the results of Phase 3 clinical studies of Fexapotide Triflutate undertaken from 2009-2016 [...]
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
30/01/2018
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]
Utah Medical Products, Inc. Reports Audited Financial Performance for Fourth Quarter and Year 2017
30/01/2018
SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq: UTMD ) concluded an outstanding year in 2017 in which it harvested distribution changes that had been in the making for several [...]

Pages